The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biologics are expected to account for approximately 17% of total global spending on medicines by 2016, and reach an overall market value of $200 billion to $210 billion in 2016, up from $157 billion in 2011. Seven of the top 10 global medicines by spending will be a biologic within the next 5 years.
Phase I healthy volunteer studies play a vital role in clinical research by providing researchers with the knowledge they need to make educated…
Data Monitoring Committee Unit
Due to increasing regulatory requirements, the need for quality study and patient safety data is critical as we work together to bring our clients’…